Literature DB >> 26483295

mDCF--new standard-of-care?

Diana Romero.   

Abstract

Mesh:

Year:  2015        PMID: 26483295     DOI: 10.1038/nrclinonc.2015.188

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.

Authors:  Manish A Shah; Yelena Y Janjigian; Ronald Stoller; Stephen Shibata; Margaret Kemeny; Smitha Krishnamurthi; Yungpo Bernard Su; Allyson Ocean; Marinela Capanu; Bhoomi Mehrotra; Paul Ritch; Charles Henderson; David P Kelsen
Journal:  J Clin Oncol       Date:  2015-11-20       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.